Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongmai Yangxin Pills (TMYX) is a traditional Chinese patent medicine composed of 11 herbs, originating from two classic prescriptions: Zhigancao Decoction and Shenmai Yin. It is primarily used for treating various cardiovascular conditions including coronary heart disease, chest pain, palpitations, angina, and irregular heartbeat. The medication works through multiple mechanisms including anti-inflammatory effects (regulating ESR1 and NF-κB signaling), cardiac pacemaking modulation (affecting HCN channels and cAMP), myocardial no-reflow improvement (activating PI3K/Akt/eNOS pathway), and intervention in ventricular remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongmai Yangxin Pills.